Related Experiment Videos
Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity
R P Warren1, J D Odell, W L Warren
1Center for Persons with Disabilities, Utah State University, Logan 84322, USA.
Insights
Attention-deficit hyperactivity disorder (ADHD) is linked to lower levels of the C4B protein, a key component of the immune system. This finding suggests C4B may be a potential biomarker or etiological factor in ADHD development.
Area of Science:
- Immunology
- Neuroscience
- Genetics
Background:
- The complement system, including C4B protein, is crucial for immune defense against pathogens.
- Understanding immune system involvement may shed light on the etiology of neurodevelopmental disorders like ADHD.
Purpose of the Study:
- To investigate plasma C4B protein levels in individuals with ADHD.
- To explore potential associations between C4B levels, infections, and ADHD development.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to quantify C4B plasma levels.
- Study included 23 subjects diagnosed with ADHD and age/sex-matched controls.
- Parental C4B levels were also assessed.
Main Results:
- ADHD subjects exhibited significantly lower C4B plasma levels (157.0 µg/mL) compared to controls (239.3 µg/mL).
- Mothers of ADHD subjects also showed significantly reduced C4B levels.
- No significant difference in C4B levels was observed in fathers.
Conclusions:
- Reduced C4B levels may serve as a potential biomarker for ADHD or specific ADHD subgroups.
- C4B protein levels could be an important etiological factor in the development of ADHD.
Objective:
The complement system is a group of blood proteins that play an important role in defending against viral and bacterial infections. The objective of this investigation was to study the plasma levels of the C4B protein in attention-deficit hyperactivity disorder (ADHD) in an attempt to associate infections with the development of some cases of this disorder.
Method:
C4B plasma protein levels were studied using an enzyme-linked immunosorbent assay in a group of 23 subjects meeting DSM-III-R criteria for ADHD and a similar number of age- and sex-matched controls. Also studied were parents of the ADHD subjects.
Results:
C4B plasma levels (157.0 micrograms/mL) in the ADHD subjects were significantly (p < .01) lower than those (239.3 micrograms/mL) in the normal age-matched subjects. Mothers of the ADHD subjects also had significantly lower C4B values compared with mothers of normal children. On the other hand, C4B values in the fathers were not significantly altered.
Conclusions:
Decreased C4B levels in ADHD, if replicated, may represent an important marker for ADHD (or a subgroup of ADHD). It also seems plausible that C4B levels are an important etiological factor for ADHD.